Literature DB >> 33608656

COVID-19-from mucosal immunology to IBD patients.

Carl Weidinger1,2, Ahmed Nabil Hegazy1,2,3, Rainer Glauben1, Britta Siegmund4.   

Abstract

Viral infections with SARS-CoV-2 can cause a multi-facetted disease, which is not only characterized by pneumonia and overwhelming systemic inflammatory immune responses, but which can also directly affect the digestive system and infect intestinal epithelial cells. Here, we review the current understanding of intestinal tropism of SARS-CoV-2 infection, its impact on mucosal function and immunology and summarize the effect of immune-suppression in patients with inflammatory bowel disease (IBD) on disease outcome of COVID-19 and discuss IBD-relevant implications for the clinical management of SARS-CoV-2 infected individuals.

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33608656      PMCID： PMC7893623          DOI： 10.1038/s41385-021-00384-9

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN： 1933-0219            Impact factor:   7.313


  53 in total

1.  Preventive medicine.

Authors:  H E Amstutz
Journal:  Mod Vet Pract       Date:  1980-04

Review 2.  Extrapulmonary manifestations of COVID-19.

Authors:  Aakriti Gupta; Mahesh V Madhavan; Kartik Sehgal; Nandini Nair; Shiwani Mahajan; Tejasav S Sehrawat; Behnood Bikdeli; Neha Ahluwalia; John C Ausiello; Elaine Y Wan; Daniel E Freedberg; Ajay J Kirtane; Sahil A Parikh; Mathew S Maurer; Anna S Nordvig; Domenico Accili; Joan M Bathon; Sumit Mohan; Kenneth A Bauer; Martin B Leon; Harlan M Krumholz; Nir Uriel; Mandeep R Mehra; Mitchell S V Elkind; Gregg W Stone; Allan Schwartz; David D Ho; John P Bilezikian; Donald W Landry
Journal:  Nat Med       Date:  2020-07-10       Impact factor: 53.440

3.  A SARS-CoV-2 mRNA Vaccine - Preliminary Report.

Authors:  Juergen R Schaefer; Yulia Sharkova; Tanja Nickolaus
Journal:  N Engl J Med       Date:  2020-08-19       Impact factor: 91.245

Review 4.  The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system.

Authors:  Francesca Coperchini; Luca Chiovato; Laura Croce; Flavia Magri; Mario Rotondi
Journal:  Cytokine Growth Factor Rev       Date:  2020-05-11       Impact factor: 7.638

5.  A Human Pluripotent Stem Cell-based Platform to Study SARS-CoV-2 Tropism and Model Virus Infection in Human Cells and Organoids.

Authors:  Liuliu Yang; Yuling Han; Benjamin E Nilsson-Payant; Vikas Gupta; Pengfei Wang; Xiaohua Duan; Xuming Tang; Jiajun Zhu; Zeping Zhao; Fabrice Jaffré; Tuo Zhang; Tae Wan Kim; Oliver Harschnitz; David Redmond; Sean Houghton; Chengyang Liu; Ali Naji; Gabriele Ciceri; Sudha Guttikonda; Yaron Bram; Duc-Huy T Nguyen; Michele Cioffi; Vasuretha Chandar; Daisy A Hoagland; Yaoxing Huang; Jenny Xiang; Hui Wang; David Lyden; Alain Borczuk; Huanhuan Joyce Chen; Lorenz Studer; Fong Cheng Pan; David D Ho; Benjamin R tenOever; Todd Evans; Robert E Schwartz; Shuibing Chen
Journal:  Cell Stem Cell       Date:  2020-06-19       Impact factor: 24.633

6.  Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples From a Hong Kong Cohort: Systematic Review and Meta-analysis.

Authors:  Ka Shing Cheung; Ivan F N Hung; Pierre P Y Chan; K C Lung; Eugene Tso; Raymond Liu; Y Y Ng; Man Y Chu; Tom W H Chung; Anthony Raymond Tam; Cyril C Y Yip; Kit-Hang Leung; Agnes Yim-Fong Fung; Ricky R Zhang; Yansheng Lin; Ho Ming Cheng; Anna J X Zhang; Kelvin K W To; Kwok-H Chan; Kwok-Y Yuen; Wai K Leung
Journal:  Gastroenterology       Date:  2020-04-03       Impact factor: 22.682

7.  COVID-19: towards understanding of pathogenesis.

Authors:  Wei Cao; Taisheng Li
Journal:  Cell Res       Date:  2020-05       Impact factor: 25.617

8.  COVID-19: consider cytokine storm syndromes and immunosuppression.

Authors:  Puja Mehta; Daniel F McAuley; Michael Brown; Emilie Sanchez; Rachel S Tattersall; Jessica J Manson
Journal:  Lancet       Date:  2020-03-16       Impact factor: 79.321

9.  Digestive Symptoms in COVID-19 Patients With Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes.

Authors:  Chaoqun Han; Caihan Duan; Shengyan Zhang; Brennan Spiegel; Huiying Shi; Weijun Wang; Lei Zhang; Rong Lin; Jun Liu; Zhen Ding; Xiaohua Hou
Journal:  Am J Gastroenterol       Date:  2020-06       Impact factor: 12.045

10.  An interactive web-based dashboard to track COVID-19 in real time.

Authors:  Ensheng Dong; Hongru Du; Lauren Gardner
Journal:  Lancet Infect Dis       Date:  2020-02-19       Impact factor: 25.071
View more
  1 in total

Review 1.  Transmembrane serine protease 2 and angiotensin-converting enzyme 2 anti-inflammatory receptors for COVID-19/inflammatory bowel diseases treatment.

Authors:  Naser-Aldin Lashgari; Nazanin Momeni Roudsari; Saeideh Momtaz; Amir Hossein Abdolghaffari
Journal:  World J Gastroenterol       Date:  2021-12-14       Impact factor: 5.742
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.